Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-31

Clinical Trial Update: Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease [NA]

View source ↗

Summary

This clinical trial update concerns magnesium sulfate as a potential cognitive treatment for Alzheimer's disease, sponsored by Metabolic Therapy Inc. The curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Metabolic Therapy Inc. | Conditions: Alzheimer Disease | NA | Status: UNKNOWN